title: Switching conventional cyclosporine treatment to microemulsion formulation in patients who need three divided doses.
authors.affiliation: Nephrology Department, Hopital Calmette, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Noël
authors.forename: M
authors.initials: M
authors.lastname: Hazzan
authors.forename: M
authors.initials: M
authors.lastname: Labalette
authors.forename: F R
authors.initials: FR
authors.lastname: Pruvot
authors.forename: A
authors.initials: A
authors.lastname: Pol
authors.forename: M
authors.initials: M
authors.lastname: Dracon
authors.forename: G
authors.initials: G
authors.lastname: Lelièvre
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine